{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:02:12Z","timestamp":1777640532116,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejmech.2018.04.016","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T16:05:47Z","timestamp":1523376347000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1048-4059","authenticated-orcid":false,"given":"Hany S.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba Abdelrasheed","family":"Allam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa R.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eslam S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.04.016_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.04.016_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbapap.2009.07.027","article-title":"Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target","volume":"1804","author":"De Simone","year":"2010","journal-title":"Biochim. Biophys. Acta Protein Proteonomics"},{"key":"10.1016\/j.ejmech.2018.04.016_bib3","series-title":"Seminars in Cancer Biology","first-page":"52","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","author":"Pastorek","year":"2015"},{"key":"10.1016\/j.ejmech.2018.04.016_bib4","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib5","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Gieling","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.ejmech.2018.04.016_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.04.016_bib8","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.04.016_bib9","first-page":"1","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","author":"Supuran","year":"2015","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib10","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","article-title":"Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.04.016_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib12","author":"U.N.I.o. Health"},{"key":"10.1016\/j.ejmech.2018.04.016_bib13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1021\/jm501798g","article-title":"Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site","volume":"58","author":"Tanpure","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejmech.2014.04.065","article-title":"Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents","volume":"80","author":"Abdel-Aziz","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib15","article-title":"Synthesis and X-Ray Structure of (1Z, 2Z)-1, 2-Bis (2-(phenylsulfonyl)-1-(4-tolyl) ethylidene) hydrazine","volume":"2014","author":"Abdel-Aziz","year":"2014","journal-title":"J.\u00a0Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib16","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1016\/j.ejmech.2009.09.002","article-title":"Stereoselective synthesis and antimicrobial activity of benzofuran-based (1E)-1-(piperidin-1-yl)-N 2-arylamidrazones","volume":"44","author":"Abdel-Aziz","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jhet.5570350221","article-title":"New isomeric N-substituted hydrazones of 2-, 3-and 4-pyridinecarboxaldehydes","volume":"35","author":"Wyrzykiewicz","year":"1998","journal-title":"J.\u00a0Het. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib18","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-014-2635-1","article-title":"Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells","volume":"75","author":"Ivanova","year":"2015","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.04.016_bib20","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/07357900802653464","article-title":"Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells","volume":"27","author":"Li","year":"2009","journal-title":"Canc. Invest."},{"key":"10.1016\/j.ejmech.2018.04.016_bib21","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","article-title":"Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis and kinetic, crystallographic, computational, and intraocular pressure lowering investigations","volume":"59","author":"Nocentini","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib22","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib23","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1002\/ejoc.201100690","article-title":"Dual secondary amine\/N-heterocyclic carbene catalysis in the asymmetric michael\/cross-benzoin cascade reaction of \u03b2-oxo sulfones with enals","volume":"2011","author":"Enders","year":"2011","journal-title":"Eur. J. Org Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/molecules21010114","article-title":"Synthesis, biological evaluation and molecular docking of certain sulfones as potential nonazole antifungal agents","volume":"21","author":"Fares","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.04.016_bib25","article-title":"Design, synthesis, and molecular docking of 1-(1-(4-chlorophenyl)-2-(phenylsulfonyl) ethylidene)-2-phenylhydrazine as potent nonazole anticandidal agent","volume":"2014","author":"Ghabbour","year":"2014","journal-title":"J.\u00a0Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib26","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1016\/j.tetlet.2011.08.035","article-title":"1-Butyl-3-methylimidazolium p-toluenesulfinate: a novel reagent for synthesis of sulfones and \u03b2-ketosulfones in ionic liquid","volume":"52","author":"Kumar","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.04.016_bib27","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1055\/s-0036-1589479","article-title":"Copper triflate mediated \u03b1-monohalogenation of \u03b1-diazo \u03b2-ketosulfones with ammonium halides","volume":"49","author":"Chan","year":"2017","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2018.04.016_bib28","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/S0040-4039(97)00734-X","article-title":"Ruthenium tetroxide catalyzed oxidations of 3-alkyl-4-(2-furyl)-4-oxobutanenitriles: synthesis of methyl 2-alkyl-3-cyanopropanoates","volume":"38","author":"Giovannini","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.04.016_bib29","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Akocak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib30","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.bmc.2017.01.008","article-title":"Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties","volume":"25","author":"Altug","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2017.07.073","article-title":"Novel 4\/3-((4-oxo-5-(2-oxoindolin-3-ylidene) thiazolidin-2-ylidene) amino) benzenesulfonamides: synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies","volume":"139","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ejmech.2015.09.021","article-title":"Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII","volume":"103","author":"Ibrahim","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmech.2017.01.017","article-title":"Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: synthesis, in\u00a0vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies","volume":"127","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib34","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1021\/acsmedchemlett.7b00369","article-title":"Benzoxaboroles as efficient inhibitors of the \u03b2-carbonic anhydrases from pathogenic fungi: activity and modeling study","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.04.016_bib35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/14756366.2017.1308928","article-title":"Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging","volume":"32","author":"Zhang","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.04.016_bib36","doi-asserted-by":"crossref","first-page":"080","DOI":"10.7324\/JAPS.2015.50313","article-title":"In\u00a0vitro cytotoxicity MTT assay in Vero, HepG2 and MCF-7 cell lines study of Marine Yeast","volume":"5","author":"Senthilraja","year":"2015","journal-title":"J.\u00a0Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2018.04.016_bib37","unstructured":"Schr\u00f6dinger Suite Release 2016-1, Schr\u00f6dinger, LLC, New York, NY, 2016: (a) Maestro v.10.5;(b) Epik, v.3.5; (c) Impact, v.7.0; (d) Prime, v.4.3; (e) Macromodel v.11.1.(f) Glide, v.7.0."},{"key":"10.1016\/j.ejmech.2018.04.016_bib38","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins: Struct. Funct. Bioinformatics"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418303519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T21:13:10Z","timestamp":1660857190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418303519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":38,"alternative-id":["S0223523418303519"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.016","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}